Skip to main content
. 2017 Nov 18;41(6):663–670. doi: 10.1007/s40618-017-0789-5

Table 1.

Clinical characteristics of the NGT and GDM participants

Variable NGT (n = 230) GDM (n = 141) p value
Age (year) 29 (25, 32) 29 (26, 32.50) 0.529
Pregestational body mass index(kg/m2) 21.604 (19.835, 23.438) 22.039 (19.988, 23.673) 0.271
Systolic blood pressure (mmHg) 110 (104, 120) 112 (102, 120) 0.267
Diastolic blood pressure (mmHg) 70 (65, 75) 70 (65.50, 78) 0.353
Alkaline phosphatase (U/L) 58 (48, 69.25) 59.5 (49, 70) 0.321
Alanine aminotransferase (U/L) 14 (10, 22) 13 (10, 21.50) 0.651
Aspartate aminotransferase (U/L) 18.50 (16, 23) 19 (15, 24) 0.840
Creatinine (μmol/L) 46.98 ± 6.18 46.67 ± 6.66 0.631
eGFR (mL/min 1.73 m2) 148.87 (135.42, 170.03) 153.45 (133.89, 169.01) 0.832
Hemoglobin A1C (%) 4.71 (4.50, 4.90) 4.90 (4.60, 5.20) 0.001**
FPG (mmol/L) 4.30 (4.00, 4.50) 4.90 (4.40, 5.90) < 0.001**
1 h-PG (mmol/L) 6.60 (5.70, 7.80) 9.50 (7.60, 10.90) < 0.001**
2 h-PG (mmol/L) 6.05 (5.30, 6.80) 8.50 (6.10, 9.20) < 0.001**
AUC for glucose (mmol/L h) 11.88 ± 1.83 15.85 ± 2.93 < 0.001**
Triglycerides (mmol/L) 2.27 (1.79, 2.91) 2.39 (1.91, 2.97) 0.241
Total cholesterol (mmol/L) 6.17 (5.64, 6.92) 6.00 (5.27, 6.93) 0.097
HDL-c (mmol/L) 1.67 (1.53, 1.88) 1.67 ± 0.29 0.269
LDL-c (mmol/L) 2.91 ± 0.74 3.00 ± 0.88 0.569
FINS (mU/L) 8.68 (5.89, 12.94) 10.26 (6.63, 15.46) 0.011*
1 h-INS (mU/L) 62.67 (43.77, 89.78) 74.23 (48.65, 117.00) 0.020*
2 h-INS (mU/L) 60.74 (40.45, 84.73) 83.925 (52.01, 134.00) < 0.001**
AUC for insulin (mU/L h) 100.45 (70.13, 136.29) 126.81 (84.55, 184.60) 0.001**
HOMA-β 248 (173.50, 367) 169.10 (93.39, 255.72) < 0.001**
HOMA-IR 1.65 (1.10, 2.49) 2.24 (1.45, 3.84) < 0.001**
Stumvoll 1st phase insulin secretion index 1393.88 (1243.77, 1714.35) 1176.93 (863.62, 1660.09) 0.001**
Stumvoll 2nd phase insulin secretion index 173.09 (139.07, 194.36) 80.79 (33.51, 141.23) 0.067

Values are presented as the mean ± SD or medians (interquartile range)

eGFR estimated glomerular filtration rate, FPG fasting plasma glucose, 1 h-PG 1-h postprandial glucose, 2 h-PG 2-h postprandial glucose, AUC for glucose area under the glucose–time curve from the 2-h OGTT, HDL high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol, FINS fasting insulin, 1 h-INS 1-h postprandial insulin, 2 h-INS 2-h postprandial insulin, AUC for insulin area under the insulin–time curve from the 2-h OGTT, HOMA-β homeostasis model assessment index of β-cell secretion, HOMA-IR homeostasis model assessment of insulin resistance

*Significantly different compared to NGT at p < 0.05

**Significantly different compared to NGT at p < 0.01